1. Home
  2. CRC vs DNTH Comparison

CRC vs DNTH Comparison

Compare CRC & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Resources Corporation

CRC

California Resources Corporation

HOLD

Current Price

$52.59

Market Cap

5.3B

Sector

Energy

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$95.75

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRC
DNTH
Founded
2014
2015
Country
United States
United States
Employees
2500
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CRC
DNTH
Price
$52.59
$95.75
Analyst Decision
Buy
Strong Buy
Analyst Count
7
13
Target Price
$72.57
$121.00
AVG Volume (30 Days)
772.3K
1.3M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,036,000.00
Revenue This Year
$12.37
N/A
Revenue Next Year
N/A
$29.48
P/E Ratio
$13.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$43.25
$18.08
52 Week High
$71.98
$96.78

Technical Indicators

Market Signals
Indicator
CRC
DNTH
Relative Strength Index (RSI) 33.34 60.28
Support Level $44.99 $79.27
Resistance Level $63.65 N/A
Average True Range (ATR) 1.83 5.49
MACD -0.30 1.53
Stochastic Oscillator 19.41 84.67

Price Performance

Historical Comparison
CRC
DNTH

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: